RxDoctor Payments DataLook up a doctor →

Jacqueline Eghrari-Sabet, MD

Allergy & Immunology · Vienna, VANPI 1295770998

Payments from drug & device makers

$1,053,136in general payments, 2019–2025

Across 1,109 payments — averaging $949.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$702K
  • Alk-abello, Inc$252K
  • Genentech USA, Inc.$43K
  • AstraZeneca$21K
  • Roche Products Limited$12K
  • Sanofi US Services Inc.$10K
  • plus $14K from 26 others
$1,603in research payments, 2019–2025

Across 2 payments — averaging $801.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi-aventis U.S. LLC$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,053,136 in reported general payments places this provider in the 95th percentile of 133 allergy & immunology providers in Virginia.

See all allergy & immunology providers in Virginia

Medicare billing

Part B allowed, 2024
$15,451
Medicare patients
42
Services billed
1,360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Vienna

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →